Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Rinaldi

Showing results (361-370 of 394) with videos related to

Pageof 40
Sort By:
Journal of Clinical Microbiology|September 17, 1998
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolatesW R Kirkpatrick, S G Revankar, R K Mcatee, et al.
Clinical Microbiology Reviews|October 5, 2001
Antifungal susceptibility testing: practical aspects and current challengesJ H Rex, M A Pfaller, T J Walsh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1997
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory StandardsJ H Rex, M A Pfaller, J N Galgiani, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2011
Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyemaBrad Moriyama, Marisa Ditullio, Eleanor Wilson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2001
Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis SurveyH M Blumberg, W R Jarvis, J M Soucie, et al.
Practical Radiation Oncology|October 1, 2020
Long-Term Results of a Prospective Phase 2 Study on Volume De-Escalation in Neoadjuvant Chemoradiotherapy of Rectal CancerMichele Fiore, Carlo Greco, Alessandro Coppola, et al.
Oral Oncology|September 23, 2008
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II studyL D Locati, P Bossi, F Perrone, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancerMarta C Dahiya, Spencer W Redding, Rajiv S Dahiya, et al.
Journal of Clinical Microbiology|August 28, 2009
Cerebral aspergillosis caused by Aspergillus granulosusDeanna A Sutton, Brian L Wickes, Anna M Romanelli, et al.
Cancers|October 14, 2023
Untailored vs. Gender- and Body-Mass-Index-Tailored Skeletal Muscle Mass Index (SMI) to Assess Sarcopenia in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)Cristina Morelli, Vincenzo Formica, Paolo Bossi, et al.
Pageof 40

Showing results (361-370 of 394) with videos related to

Sort By:
Pageof 40
Journal of Clinical Microbiology|September 17, 1998
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolatesW R Kirkpatrick, S G Revankar, R K Mcatee, et al.
Clinical Microbiology Reviews|October 5, 2001
Antifungal susceptibility testing: practical aspects and current challengesJ H Rex, M A Pfaller, T J Walsh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1997
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory StandardsJ H Rex, M A Pfaller, J N Galgiani, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2011
Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyemaBrad Moriyama, Marisa Ditullio, Eleanor Wilson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2001
Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis SurveyH M Blumberg, W R Jarvis, J M Soucie, et al.
Practical Radiation Oncology|October 1, 2020
Long-Term Results of a Prospective Phase 2 Study on Volume De-Escalation in Neoadjuvant Chemoradiotherapy of Rectal CancerMichele Fiore, Carlo Greco, Alessandro Coppola, et al.
Oral Oncology|September 23, 2008
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II studyL D Locati, P Bossi, F Perrone, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancerMarta C Dahiya, Spencer W Redding, Rajiv S Dahiya, et al.
Journal of Clinical Microbiology|August 28, 2009
Cerebral aspergillosis caused by Aspergillus granulosusDeanna A Sutton, Brian L Wickes, Anna M Romanelli, et al.
Cancers|October 14, 2023
Untailored vs. Gender- and Body-Mass-Index-Tailored Skeletal Muscle Mass Index (SMI) to Assess Sarcopenia in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)Cristina Morelli, Vincenzo Formica, Paolo Bossi, et al.
Pageof 40